Does LAMIVUDINE Cause Exposure during breast feeding? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Exposure during breast feeding have been filed in association with LAMIVUDINE (Lamivudine and Zidovudine). This represents 0.6% of all adverse event reports for LAMIVUDINE.
102
Reports of Exposure during breast feeding with LAMIVUDINE
0.6%
of all LAMIVUDINE reports
43
Deaths
1
Hospitalizations
How Dangerous Is Exposure during breast feeding From LAMIVUDINE?
Of the 102 reports, 43 (42.2%) resulted in death, 1 (1.0%) required hospitalization.
Is Exposure during breast feeding Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does LAMIVUDINE Cause?
Foetal exposure during pregnancy (1,905)
Virologic failure (1,894)
Drug resistance (1,889)
Pathogen resistance (1,733)
Viral mutation identified (1,631)
Treatment failure (933)
Exposure during pregnancy (846)
Drug interaction (744)
Drug ineffective (726)
Immune reconstitution inflammatory syndrome (625)
What Other Drugs Cause Exposure during breast feeding?
COPPER (412)
ADALIMUMAB (215)
FLUOXETINE (122)
NEVIRAPINE (117)
BUPRENORPHINE (110)
LEVONORGESTREL (102)
ZIDOVUDINE (93)
BUPRENORPHINE\NALOXONE (83)
NICOTINE (81)
INSULIN LISPRO (74)
Which LAMIVUDINE Alternatives Have Lower Exposure during breast feeding Risk?
LAMIVUDINE vs LAMIVUDINE\NEVIRAPINE\ZIDOVUDINE
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR DISOPROXIL
LAMIVUDINE vs LAMIVUDINE\ZIDOVUDINE
LAMIVUDINE vs LAMOTRIGINE